European phase II study of mogamulizumab, an anti-CCR4 monoclonal antibody, in relapsed/refractory peripheral T-cell lymphoma.
Authors
Zinzani, PKarlin, L
Radford, John A
Caballero, D
Fields, P
Chamuleau, M
D' Amore, F
Haioun, C
Thieblemont, C
González-Barca, E
Grande García, C
Johnson, P
van Imhoff, G
Ng, T
Dwyer, K
Morschhauser, F
Affiliation
Policlinico S. Orsola, University of Bologna, Bologna, ItalyIssue Date
2016-07-14
Metadata
Show full item recordCitation
European phase II study of mogamulizumab, an anti-CCR4 monoclonal antibody, in relapsed/refractory peripheral T-cell lymphoma. 2016: HaematologicaJournal
HaematologicaDOI
10.3324/haematol.2016.146977PubMed ID
27418646Type
ArticleISSN
1592-8721ae974a485f413a2113503eed53cd6c53
10.3324/haematol.2016.146977
Scopus Count
Collections
Related articles
- Multicenter phase II study of mogamulizumab (KW-0761), a defucosylated anti-cc chemokine receptor 4 antibody, in patients with relapsed peripheral T-cell lymphoma and cutaneous T-cell lymphoma.
- Authors: Ogura M, Ishida T, Hatake K, Taniwaki M, Ando K, Tobinai K, Fujimoto K, Yamamoto K, Miyamoto T, Uike N, Tanimoto M, Tsukasaki K, Ishizawa K, Suzumiya J, Inagaki H, Tamura K, Akinaga S, Tomonaga M, Ueda R
- Issue date: 2014 Apr 10
- Safety and effectiveness of mogamulizumab in relapsed or refractory CC chemokine receptor 4-positive peripheral T-cell lymphoma and relapsed or refractory cutaneous T-cell lymphoma: A post-marketing surveillance in Japan.
- Authors: Ishitsuka K, Yasukawa T, Tsuji Y
- Issue date: 2024 Jul
- Phase I study of KW-0761, a defucosylated humanized anti-CCR4 antibody, in relapsed patients with adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma.
- Authors: Yamamoto K, Utsunomiya A, Tobinai K, Tsukasaki K, Uike N, Uozumi K, Yamaguchi K, Yamada Y, Hanada S, Tamura K, Nakamura S, Inagaki H, Ohshima K, Kiyoi H, Ishida T, Matsushima K, Akinaga S, Ogura M, Tomonaga M, Ueda R
- Issue date: 2010 Mar 20
- Mogamulizumab: An Anti-CC Chemokine Receptor 4 Antibody for T-Cell Lymphomas.
- Authors: Moore DC, Elmes JB, Shibu PA, Larck C, Park SI
- Issue date: 2020 Apr
- Clinical Application of Anti-CCR4 Monoclonal Antibody.
- Authors: Ueda R
- Issue date: 2015